Brilliance: Research of Artificial Intelligence
Vol. 2 No. 2 (2022): Brilliance: Research of Artificial Intelligence, Article Research May 2022

Escherichia coli spp, Staph albus and Klebseilla spp were affected by some Antibiotics for Urinary Tract Infections in Bani Waleed City

Alla Abdulmutalib Mohammed (Department of Pharmacy Higher Institute of Medical Sciences, Bani Waleed, Libya)
Abdul Samad (Faculty of veterinary and Animal Sciences MNS University of Agriculture 25000, Multan, Pakistan)
Ola Adrees Omar (Department of Pharmacy Higher Institute of Medical Sciences, Bani Waleed, Libya)



Article Info

Publish Date
11 Jun 2022

Abstract

In a statistical research of 100 women diagnosed with urinary tract infections (UTIs) at Al Dhahirah Hospital - Ibn Sina Clinic - Aqaba Laboratory for Medical Analysis in the city of Bani Waleed in 2017, Agrahl (Ibrahim, H. K., Mohammed, A. A., & Omar, O. A. (2018).) and (Ibrahim, Hamza Khalifa). (2017). found that the most affected age group is the most common. The illness afflicted (26-30) years by 39 percent, making it the most affected age group when compared to others. The antibiotic (Augmentin) was shown to be the most important and effective antibiotic used in the treatment of urinary tract infection during this time period, accounting for 49 percent of cases, while UTI is more frequent in the winter, with a 59 percent infection rate. The increasing resistance to bacteria of our isolates under investigation might be related to the widespread use of antibiotics at random, allowing for a rise in bacterial resistance to various antibiotics.

Copyrights © 2022






Journal Info

Abbrev

brilliance

Publisher

Subject

Decision Sciences, Operations Research & Management Mathematics Other

Description

Brilliance: Research of Artificial Intelligence is The Scientific Journal. Brilliance is published twice in one year, namely in February, May and November. Brilliance aims to promote research in the field of Informatics Engineering which focuses on publishing quality papers about the latest ...